ATE253066T1 - Imidazotriazinderivate als gaba rezeptor-liganden - Google Patents

Imidazotriazinderivate als gaba rezeptor-liganden

Info

Publication number
ATE253066T1
ATE253066T1 AT00954717T AT00954717T ATE253066T1 AT E253066 T1 ATE253066 T1 AT E253066T1 AT 00954717 T AT00954717 T AT 00954717T AT 00954717 T AT00954717 T AT 00954717T AT E253066 T1 ATE253066 T1 AT E253066T1
Authority
AT
Austria
Prior art keywords
receptor ligands
gaba receptor
optionally substituted
derivatives
imidazotriazine
Prior art date
Application number
AT00954717T
Other languages
English (en)
Inventor
William Robert Terling Carling
Alexander Richard Guiblin
Kevin William Moore
Christopher Richard Moyes
Michael Rowley
Leslie Joseph Street
Original Assignee
Merck Sharp & Dohme
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck Sharp & Dohme filed Critical Merck Sharp & Dohme
Application granted granted Critical
Publication of ATE253066T1 publication Critical patent/ATE253066T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics
AT00954717T 1999-08-23 2000-08-17 Imidazotriazinderivate als gaba rezeptor-liganden ATE253066T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB9919957.2A GB9919957D0 (en) 1999-08-23 1999-08-23 Therapeutic agents
PCT/GB2000/003199 WO2001014377A1 (en) 1999-08-23 2000-08-17 Imidazo-triazine derivatives as ligands for gaba receptors

Publications (1)

Publication Number Publication Date
ATE253066T1 true ATE253066T1 (de) 2003-11-15

Family

ID=10859670

Family Applications (1)

Application Number Title Priority Date Filing Date
AT00954717T ATE253066T1 (de) 1999-08-23 2000-08-17 Imidazotriazinderivate als gaba rezeptor-liganden

Country Status (10)

Country Link
US (1) US6608062B1 (de)
EP (1) EP1212324B1 (de)
JP (1) JP2003507479A (de)
AT (1) ATE253066T1 (de)
AU (1) AU775008B2 (de)
CA (1) CA2380452C (de)
DE (1) DE60006260T2 (de)
ES (1) ES2208404T3 (de)
GB (1) GB9919957D0 (de)
WO (1) WO2001014377A1 (de)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9923078D0 (en) * 1999-09-29 1999-12-01 Phytopharm Plc Sapogenin derivatives and their use
GB0210127D0 (en) * 2002-05-02 2002-06-12 Merck Sharp & Dohme Therapeutic agents
CA2493883C (en) * 2002-07-12 2011-08-30 Japan Science And Technology Agency Drugs for improving the prognosis of brain injury and a method of screening the same
EP2258359A3 (de) 2005-08-26 2011-04-06 Braincells, Inc. Neurogenese durch Modulation des Muscarinrezeptors mit Sabcomelin
JP2009506069A (ja) 2005-08-26 2009-02-12 ブレインセルス，インコーポレイティド ムスカリン性受容体調節による神経発生
AU2006304787A1 (en) 2005-10-21 2007-04-26 Braincells, Inc. Modulation of neurogenesis by PDE inhibition
CA2625210A1 (en) 2005-10-31 2007-05-10 Braincells, Inc. Gaba receptor mediated modulation of neurogenesis
KR20080080206A (ko) 2005-12-20 2008-09-02 아스트라제네카 아베 Ｇａｂａａ-수용체 조절제로서의 치환된 신놀린 유도체 및그의 합성 방법
US7465795B2 (en) 2005-12-20 2008-12-16 Astrazeneca Ab Compounds and uses thereof
US20100216734A1 (en) 2006-03-08 2010-08-26 Braincells, Inc. Modulation of neurogenesis by nootropic agents
EP2377531A2 (de) 2006-05-09 2011-10-19 Braincells, Inc. Neurogenese mittels Angiotensin-Modulation
EP2026813A2 (de) 2006-05-09 2009-02-25 Braincells, Inc. 5-ht-rezeptor-vermittelte neurogenese
US7998971B2 (en) 2006-09-08 2011-08-16 Braincells Inc. Combinations containing a 4-acylaminopyridine derivative
GB0622472D0 (en) * 2006-11-10 2006-12-20 Addex Pharmaceuticals Sa Novel heterocyclic derivatives
US20100216805A1 (en) 2009-02-25 2010-08-26 Braincells, Inc. Modulation of neurogenesis using d-cycloserine combinations
IL310992A (en) * 2021-08-25 2024-04-01 Ptc Therapeutics Inc NLRP3 inhibitors

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3422194A (en) 1967-08-15 1969-01-14 Smithkline Corp The treatment of depression with imidazo(1,2-b)-as-triazines and compositions thereof
SK9399A3 (en) 1996-07-25 2000-04-10 Merck Sharp & Dohme Substituted triazolo-pyridazine derivatives as ligands for gaba receptors
DE69936998T2 (de) 1998-10-16 2008-05-21 Merck Sharp & Dohme Ltd., Hoddesdon Pyrazolotriazinderivate als gaba-rezeptorliganden

Also Published As

Publication number Publication date
AU6707700A (en) 2001-03-19
CA2380452C (en) 2008-10-28
AU775008B2 (en) 2004-07-15
CA2380452A1 (en) 2001-03-01
GB9919957D0 (en) 1999-10-27
WO2001014377A1 (en) 2001-03-01
JP2003507479A (ja) 2003-02-25
US6608062B1 (en) 2003-08-19
EP1212324B1 (de) 2003-10-29
EP1212324A1 (de) 2002-06-12
DE60006260D1 (de) 2003-12-04
ES2208404T3 (es) 2004-06-16
DE60006260T2 (de) 2004-07-29

Similar Documents

Publication Publication Date Title
GB9927687D0 (en) Therapeutic agents
ATE284403T1 (de) Triazolopyridazinderivate als liganden für gaba- rezeptoren
DE60006260D1 (de) Imidazotriazinderivate als gaba rezeptor-liganden
ATE338758T1 (de) Imidazopyrimidin-derivate als liganden für gaba- rezeptoren
GB0117277D0 (en) Therapeutic agents
BG104671A (en) Triazolo-pyridazine derivatives as ligands for gaba receptors
DE60115282D1 (de) Imidazotriazin-derivate als liganden für gaba-rezeptoren
YU2899A (sh) Supstituisani triazolo-piridazin derivati kao ligandi za gaba receptore
GB0212048D0 (en) Therapeutic agents
DE69911374D1 (de) Triazolopiridazinederivate als gaba rezeptor-liganden
ATE255109T1 (de) Imidazopyridinderivate als gaba rezeptor liganden
BG108166A (en) Imidazo-pyrimidine derivatives as liigands for gaba receptors
DE60307462D1 (de) 8-fluorimidazo(1,2-a)pyridin derivative als liganden für gaba rezeptoren
DE69936998D1 (de) Pyrazolotriazinderivate als gaba-rezeptorliganden
DE60325865D1 (de) Phenylpyridazin derivative als liganden für gaba-rezeptoren
PE44299A1 (es) Derivados sustituidos de triazolo-piridacina como ligandos para receptores gaba
CA2260774A1 (en) Substituted triazolo-pyridazine derivatives as ligands for gaba receptors
JO2312B1 (en) Imidazo-pyrimidine derivatives as associative groups of JABA receptors
TR200002100T2 (tr) GABA reseptörleri için ligandlar olarak triazolo-piridazin türevleri
ATE252103T1 (de) 6-substituierte 1,2,4a,5a,8a,8b-hexahydro- und 1, 2,3,4,4a,5a,8a,8b-oktahydro-6h-pyrrolo(3',4':4, 5)furo(3,2-b)pyrid-8(7h)-on derivate und ihre verwendung zur bekämpfung von endoparasiten

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties